Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.
about
New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015Oncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesEndogenous retroviral promoter exaptation in human cancerThe heterogeneous landscape of ALK negative ALCL.Transposable Elements in Human Cancer: Causes and Consequences of DeregulationAdult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and managementTherapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.A novel isoform of IL-33 revealed by screening for transposable element promoted genes in human colorectal cancerGenetic Landscape and Classification of Peripheral T Cell Lymphomas.Transposable elements in cancer.Making a virtue of necessity: the pleiotropic role of human endogenous retroviruses in cancer.Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling.Are we ready to take full advantage of patient-derived tumor xenograft models?DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma.The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with rearrangements
P2860
Q26767492-014D5E1C-CB8E-4443-9C92-7AC7E5C1B369Q26768158-B1AED59B-6476-409D-85AC-AADC91D2CE23Q28067477-F53E22B7-1C00-4A92-8730-2598436E64EEQ33567012-0D5F6C53-A995-491F-84ED-9993A87BC45BQ36362814-6F5B1A52-8931-451C-99E6-A35634B7E39AQ36926529-DEC8E15F-B79B-485B-848E-068B095221C8Q38409231-450D0D25-44A3-4F9E-83B1-90E8C271B0F7Q38675614-C83E413F-0D9E-43A4-891F-30358E5015FDQ39183278-66BDEE83-B112-41FA-94AC-8FAA311AC225Q39392722-B8E67AC7-0D8A-41D1-8D18-7BD7D50B334EQ40046573-822CDAF9-0326-463D-9120-85C6F8E8F623Q41004137-B7AF7301-F524-465F-AFAB-D8D0D352D588Q46530451-945AAA13-F752-4152-8DDC-623E84E06231Q48099042-66154C92-64B1-4B7D-AA23-7C9FD08BA967Q48124941-A944A894-1D0C-4E15-9ACE-2CE546B4008AQ50061844-F9CBFD1B-7862-4DEC-86D4-07DD7567EE88Q54117760-EE34A50D-9E03-4FB1-A0CB-E5DCEDB60BBEQ57788453-042043B4-3B23-4C9A-954C-3703DAAFDA41
P2860
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Identification of a new subcla ...... t levels of ERBB4 transcripts.
@en
type
label
Identification of a new subcla ...... t levels of ERBB4 transcripts.
@en
prefLabel
Identification of a new subcla ...... t levels of ERBB4 transcripts.
@en
P2093
P50
P1433
P1476
Identification of a new subcla ...... t levels of ERBB4 transcripts.
@en
P2093
Andrea Rinaldi
Antonella Barreca
Domenico Novero
Elisabetta Mereu
Enrico Tiacci
European T-Cell Lymphoma Study Group
Francesco Abate
Giorgio Inghirami
Giulia Garaffo
Irene Scarfò
P304
P356
10.1182/BLOOD-2014-12-614503
P407
P50
P577
2015-10-13T00:00:00Z